Mammography utilization in Canadian women aged 50 to 69: Identification of factors that predict initiation and adherence

Canadian Journal of Public Health

Volumn 96, Issue 5, 2005, Pages 364-368

  Bancej, Christina M ^a   Maxwell, Colleen J ^b   Onysko, Jay ^a   Eliasziw, Michael ^b  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cohort studies; Health behaviours; Mammography; Mass screening; Surveys

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREAST CANCER; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; ECHOMAMMOGRAPHY; EDUCATION; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERVIEW; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SCREENING TEST; SOCIAL ASPECT; URBAN POPULATION;

EID: 26844436882     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404034     Document Type: Article

References (50)

1. National Cancer Institute of Canada. Canadian Cancer Statistics 2002. Toronto, ON, 2002.
2. National Cancer Institute of Canada. Canadian Cancer Statistics 2003. Toronto, ON, 2004.
3. Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000;36(6):724-35.
4. WHO: International Agency for Research on Cancer. Handbook for Cancer Prevention, Breast Cancer Screening. Vol. 7 edition, IARC Press, 2002.
5. Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman EA, Fracheboud J, et al. Breast cancer screening in 21 countries: Delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 1999;8(5):417-26.
6. Health Canada. Organized Breast Screening Programs in Canada: 1999 and 2000 Report. Ottawa, ON: Minister of Public Works and Government Services Canada, 2003.
7. World Health Organization. National Cancer Control Programmes. Policies and Managerial Guidelines. Geneva, Switzerland: WHO, 1995.
8. Europe Against Cancer. European Guidelines for Quality Assurance in Mammographic Screening. Luxembourg: Office for Official Publications of the European Communities, 2001.
9. NHSBSP. Standards for the NHS Breast Screening Programme (updated August 1998). Sheffield, England: NHSBSP Publication, 1998.
10. Health Canada. Report from the Evaluation Indicators Working Groups, Guidelines for Monitoring Breast Screening Program Performance. Ottawa, ON: Minister of Public Works and Government Services Canada, 2002.
11. Tudiver F, Fuller-Thomson E. Who has screening mammography? Results from the 1994-1995 National Population Health Survey. Can Fam Phys 1999;45:1901-7.
12. Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care 1991;29(8):697-707.
13. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women's adherence to mammography screening guidelines. Health Serv Res 1998;33(1):29-53.
14. Maxwell CJ, Bancej CM, Snider J. Predictors of mammography use among Canadian women aged 50-69: Findings from the 1996/97 National Population Health Survey. CMAJ 2001;164(3):329-34.
15. Johnson MM, Hislop TG, Kan L, Coldman AJ, Lai A. Compliance with the screening mammography program of British Columbia: Will she return? Can J Public Health 1996;87(3):176-80.
16. Song L, Fletcher R. Breast cancer rescreening in low-income women. Am J Prev Med 1998;15(2):128-33.
17. Sabogal F, Merrill SS, Packel L. Mammography rescreening among older California women. Health Care Financ Rev 2001;22(4):63-75.
18. Burns RB, Freund KM, Ash A, Shwartz M, Antab L, Hall R. Who gets repeat screening mammography: The role of the physician. J Gen Intern Med 1995;10(9):520-22.
19. Elwood M, McNoe B, Smith T, Bandaranayake M, Doyle TC. Once is enough - why some women do not continue to participate in a breast cancer screening programme. N Z Med J 1998;111(1066):180-83.
20. Fine MK, Rimer BK, Watts P. Women's responses to the mammography experience. J Am Board Fam Pract 1993;6(6):546-55.
21. Snider J, Beauvais J, Levy I, Villeneuve P, Pennock J. Trends in mammography and Pap smear utilization in Canada. Chron Dis Can 1996;17(3-4):108-17.
22. Maxwell CJ, Kozak JF, Desjardins-Denault SD, Parboosingh J. Factors important in promoting mammography screening among Canadian women. Can J Public Health 1997;88(5):346-50.
23. Tambay JL, Catlin G. Sample design of the National Population Health Survey. Health Rep 1995;7(1):29-38,31-42.
24. Swain L, Catlin G, Beaudet MP. The National Population Health Survey - its longitudinal nature. Health Rep 1999;10(4):69-82(ENG); 73-89(FRE).
25. Statistics Canada. National Population Health Survey (NPHS) Cycle 3 (1998-1999) Public Use Microdata Documentation. 2000.
26. Degnan D, Harris R, Ranney J, Quade D, Earp JA, Gonzalez J. Measuring the use of mammography: Two methods compared. Am J Public Health 1992;82(10):1386-88.
27. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993;85(7):566-70.
28. Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996;5(9):721-26.
29. Fulton-Kehoe D, Burg MA, Lane DS. Are self-reported dates of mammograms accurate? Public Health Rev 1992-1993;20(3-4):233-40.
30. Jelinski SE, Maxwell CJ, Onysko J, Bancej CM. The influence of breast self-examination on subsequent mammography participation. Am J Public Health 2005;95(3):506-11.
31. Bancej CM, Maxwell CJ, Snider J. Inconsistent self-reported mammography history: Findings from the National Population Health Survey longitudinal cohort. BMC Health Serv Res 2004;4(1):32.
32. Robbins AS, Chao SY, Fonseca VP. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol 2002;12(7):452-54.
33. Partin MR, Slater JS. Promoting repeat mammography use: Insights from a systematic needs assessment. Health Educ Behav 2003;30(1):97-112.
34. Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 1994;16(1):79-86.
35. McBride CM, Curry SJ, Taplin S, Anderman C, Grothaus L. Exploring environmental barriers to participation in mammography screening in an HMO. Cancer Epidemiol Biomarkers Prev 1993;2(6):599-605.
36. Messina CR, Kabat GC, Lane DS. Perceptions of risk factors for breast cancer and attitudes toward mammography among women who are current, ex- and non-smokers. Women Health 2002;36(3):65-82.
37. Simces Z. Community Development Pilot Projects. BC Cancer Agency Care and Research, 2002.
38. Cancer Care Ontario. Resource kit for providers/outreach workers who promote screening among Chinese women over 50. 2004.
39. Willow Breast Cancer Support and Resource Services. Responding to diversity, Phase I (1999) and Phase II (2000): A research project of Willow Breast Cancer Support and Resource Services.
40. St.Stephen's Community House Toronto. Serà que Tenho Cancer na Mama? [Educational Fotonovela for use by Portuguese women]. 2003.
41. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114(8):657-61.
42. Rimer BK, Trock B, Engstrom PF, Lerman C, King E. Why do some women get regular mammograms? Am J Prev Med 1991;7(2):69-74.
43. Urban N, Taplin SH, Taylor VM, Peacock S, Anderson G, Conrad D, et al. Community organization to promote breast cancer screening among women ages 50-75. Prev Med 1995;24(5):477-84.
44. Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 1991;41(349):320-22.
45. Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, et al. Mammography use among socio-demographically diverse women: The accuracy of self-report. Am J Public Health 1996;86(7):1016-21.
46. King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How valid are mammography self-reports? Am J Public Health 1990;80(11):1386-88.
47. Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med 1995;11(2):94-98.
48. Warnecke RB, Sudman S, Johnson TP, O'Rourke D, Davis AM, Jobe JB. Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol 1997;146(11):982-92.
49. McGovern PG, Lurie N, Margolis KL, Slater JS. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med 1998;14(3):201-8.
50. Newell SA, Girgis A, Sanson-Fisher RW, Savolainen NJ. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: A critical review. Am J Prev Med 1999;17(3):211-29.